Evaluation of plasma alpha-2-macroglobulin and interactions with tumour necrosis factor-alpha in horses with endotoxemic signs

Canadian Journal of Veterinary Research

Volumn 60, Issue 2, 1996, Pages 150-157

  Coté, Nathalie ^a   Trout, Donald R ^a   Hayes, Anthony M ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 MACROGLOBULIN; METHYLAMINE; PLASMA PROTEIN; RADIOACTIVE IODINE; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ANIMAL DISEASE; ARTICLE; AUTORADIOGRAPHY; BACTEREMIA; BLOOD; COLIC; COMPARATIVE STUDY; HEART RATE; HORSE; HORSE DISEASE; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; PATHOPHYSIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; REFERENCE VALUE; TOXEMIA;

ALPHA-MACROGLOBULINS; ANIMALS; AUTORADIOGRAPHY; BACTEREMIA; BLOOD PROTEINS; COLIC; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HEART RATE; HORSE DISEASES; HORSES; HUMANS; IODINE RADIOISOTOPES; METHYLAMINES; RECOMBINANT PROTEINS; REFERENCE VALUES; TOXEMIA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030120342     PISSN: 08309000     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. BURROWS GE. Hemodynamic alterations in the anesthetized pony produced by slow intravenous administration of Escherichla coli endotoxin. Am J Vet Res 1970; 31: 1975-1982.
2. ELIN RJ, WOLFF SM. Biology of endotoxin. Ann Rev Med 1976; 27: 127-141.
3. LUDERITZ O, GALANOS C, LEHMANN V, et al. Lipid A: Chemical structure and biological activity. J Infect Dis 1973; 128(suppl): 17-29.
4. MORRIS DM. The contribution of macrophages to equine endotoxemia: LPS-induced mediator production by equine peritoneal macrophages. Proc Am Col Vet Int Med 1989: 484-487.
5. 2 (epoprostenol), and the hemodynamic changes in equine endotoxin shock. Am J Vet Res 1982; 43: 999-1002.
6. OETTINGER W, BERGER D, BERGER HG. The clinical significance of prostaglandins and thromboxane as mediators of septic shock. Klin Wochenschr 1987; 65: 61-68.
7. BEUTLER B, MAHONEY J, LE TRANG N, PEKALA P, CERAMI A. Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells. J Exp Med 1985; 161: 984-995.
8. KAWAKAMI M, CERAMI A. Studies of endotoxin-induced decrease in lipoprotein lipase activity. J Exp Med 1981; 154: 631-639.
9. BEUTLER BA, MILSARK IW, CERAMI AC. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 1985; 229: 869-871.
10. KUNKEL SL, REMICK DG, STRIETER RM, LARRICK JW. Mechanisms that regulate the production and effects of tumor necrosis factor-α. Critical Rev Immunol 1989; 9: 93-116.
11. TRACEY KJ, BEUTLER B, LOWRY SF, MERRYWEATHER J, WOLPE S, MILSARK IW, HARIRI RJ, FAHEY III TJ, ZENTELLA A, ALBERT JD, SHIRES T, CERAMI A. Shock and tissue injury induced by recombinant human cachectin. Science 1986; 234: 470-474.
12. KETTELHUT C, FIERS W, GOLDBERG AL. The toxic effects of tumor necrosis factor in vivo and their prevention by cyclo-oxygenase inhibitors. Proc Natl Acad Sci USA 987; 84: 4273-4277.
13. REMICK DG, KUNKEL RG, LARRICK JW, KUNKEL SL. Acute in vivo effects of human recombinant tumor necrosis factor. Lab Invest 1987; 56: 583-590.
14. BACHWICH PR, CHENSUE SW, LARRICK JW, KUNKEL SL. Tumor necrosis factor stimulates interleukin-1 and prostaglandin E, production in resting macrophaaes Biochem Biophys Res Commun 1986; 136: 94-101.
15. 2 production by human synovial cells and dermal fibroblasts. J Exp Med 1985; 162: 2163-2168.
16. KAWAKAMI M, ISHIBASHI S, OGAWA H, MURASE T, TAKAKU F, SHIBATA S. Cachectin/TNF as well as interleukin-1 induces prostacyclin synthesis in cultured vascular endothelial cells. Biochem Biophys Res Commun 1986, 141: 482-487
17. ZUCALI JR, BROXMEYER HE, GROSS MA. DINARELLO CA. Recombinant tumor necrosis factor α and β stimulate fibrobiasts to produce hematopoietic growth factors in vitro. J Immunol 1987; 140: 840-844.
18. LE J, WEINSTEIN D, GUBLER U, VILCEK J. Induction of membrane associated interleukin-1 by tumor necrosis factor in human fibrobiasts. J Immunol 1984; 138: 2137-2142.
19. DINARELLO CA, CANNON JG, WOLFF SM, BERNHEIM HA, BEUTLER B, CERAMI A, FIGARI IS, PALLADINO MA JR, O'CONNOR JV. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med 1986; 163: 1433-1450.
20. VILCEK J, PALOMBELLA VJ, HENRIKSEN-DESTEFANO D, SWENSON C, FEINMAN R, HIRAI M, TSUJIMOTO M. Fibroblast growth factor enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factor. J Exp Med 1986; 163: 632-643.
21. ESMON CT. The regulation of natural anticoagulant pathways. Science 1987; 235: 1348-1352.
22. BROUDY VC, HARLAN JM, ADAMSON JW. Disparate effects of tumor necrosis factor-α/cachectin and tumor necrosis factor β/lymphotoxin on hematopoietic growth factor production and neutrophil adhesions molecular expression by cultured human endothelial cells. J Immunol 1987; 138: 4298-4302.
23. BROUDY VC, KAUSHANSKY K, SEGAL GM, HARLAN JM, ADAMSON JW. Tumor necrosis factor-α stimulates human endothelial cells to produce granulocyte/macrophage colony stimulating factor. Proc Natl Acad Sci USA 1986; 83: 7467-7471.
24. 2 production in resting macrophages. Biochem Biophys Res Commun 1986; 136: 94-101.
25. CASMUSSI G, BUSSOLINO F, SALVIDIO G, BAGLIONI C. Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymophonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factor. J Exp Med 1987; 166: 1390-1404.
26. SUSCHEK C, ROTHE H, FEKSEL K, ENCZMANN J, KOLB-BACHOVER V. Induction of a macrophage-like nitric oxide synthase in cultured aortic endothelial cells. II-1 beta-mediated induction regulated by tumor necrosis factor alpha and IFN-gamma. J Immunol 1993; 151: 3283-3291
27. CRONSTEIN BN, WEISSMANN G. The adhesion molecules of inflammation. Arthr Rheum 1993; 36: 147-157.
28. JÄÄTTELÄ M. Biologic activities and mechanisms of action of tumor necrosis factor α/cachectin. Lab Invest 1991; 64: 724-742.
29. RENESTO P, CHIGNARD M. Tumor necrosis factor-α enhances platelet activation via cathepsin G released form neutrophils. J Immunol 1991; 146: 2305-2309.
30. THACEY KM, FONG W, HESS DG, MANOGUE KR, LEE AT, KUO GC, LOWRY SF, CERAMI A. Anticachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteremia. Nature 1987; 330: 662-664.
31. 2-macroglobulin. J Exp Med 1977; 145: 1580-1589.
32. 2-macroglobulin with proteinases. Characteristics and specificity of the reaction, and a hypothesis concerning its molecular mechanism. Biochem J 1973; 133: 709-724.
33. 2-macroglobulin molecule. J Biochem 1979; 181: 401-418.
34. 2M after derivatization by methylamine and by factor XIII. J Biol Chem 1981; 256: 9016-9022.
35. 2-macroglobulin. J Biol Chem 1981; 256: 8134-8139.
36. DEBANNE MT, BELL R, DOLOVICH J. Uptake of protemase-α-macroglobulin complexes by macrophages. Biochim Biophys Acta 1975; 411: 295-304.
37. 2-macroglobulin. J Biol Chem 1989; 264: 5818-5825.
38. 2-macroglobulin as a carrier protein for IL-6. J Immunol 1989; 142: 148-152.
39. 2-macroglobulin. Proc Natl Acad Sci USA 1984; 81: 342-346.
40. O'CONNOR-MCCOURT MD, WAKEFIELD LM. Latent transforming growth factor-β in serum. J Biol Chem 1987; 262: 14090-14099.
41. 2-macroglobulin complex is a latent form of transforming growth factor β. J Biol Chem 1988; 263: 1535-1541.
42. LAMARRE J, WOLLENBERG GK, GAULDIE J, HAYES MA. Alpha-2-macroglobulin and serum preferentially counteract the mitoinhibitory effect of TGF-β2 in rat hepatocytes. Lab Invest 1990; 62: 545-551.
43. 2-Maeroglobulin is a binding protein for basic fibroblast growth factor. J Biol Chem 1989; 264: 7210-7216.
44. 2-macroglobulin. Am J Pathol 1991; 138: 265-272.
45. 2-macroglobulin, its receptor. and related proteins. Ann NY Acad Sci 1994; 737: 273-290.
46. GONIAS SL, BALBER AE, HUBBARD WJ, PIZZO SV. Ligand binding, conformational change and plasma elimination of human, mouse and rat α-macroglobulin proteinase inhibitors. Biochem J 1983; 209: 99-105.
47. 2-macroglobulin with cleavage of the thiol ester bonds by methylamine. Arch Biochem Biophys 1988; 262: 517-524.
48. 2-macroglobulin. J Biol Chem 1984; 259: 458-4462.
49. LASSON A, OHLSSON K. Protease inhibitors in acute human pancreatitis. Correlation between biochemical changes and clinical course. Scand J Gastroenterol 1984; 19: 779-886.
50. MCMAHON MJ, BOWEN M, MAYER AD, COOPER EH. Relation of a, macroglobulin and other proteinases to the clinical features of acute pancreatitis. Am J Surg 1984; 147: 164-170.
51. 2 macroglobulin-protease complexes in severe and mild attacks. Gut 1991; 32: 430-434.
52. BEUTLER B, MILSARK IW, CERAMI A. Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo. J Immunol 1985; 135: 3972-3977.
53. MORRIS DD, CROWE N, MOORE JN. Correlation of clinical and laboratory data with serum tumor necrosis factor activity in horses with experimentally induced endotoxemia. Am J Vet Res 1990; 51: 1935-1939.
54. MICHIE HR, MANOGUE KR, SPRIGGS DR, REVHAUG A, O'DWYER S, DINARELLO CA, CERAMI A, WOLFF SM, WILMORE DW. Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 1988; 318: 1481-1486.
55. MACKAY RJ, MERRITT AM, ZERTUCHE JM, WHITTINGTON M, SKELLEY LA. Tumor necrosis factor activity in the circulation of horses given endotoxin. Am J Vet Res 1991; 52: 533-538.
56. ALLEN GK, GREEN EM, ROBINSON JA, GARNER HE, LOCH WE, WALSH DM. Serum tumor necrosis factor alpha concentrations and clinical abnormalities in colostrum-fed and colostrum-deprived neonatal foals given endotoxin. Am J Vet Res 1993; 54: 1404-1410.
57. MACKAY RJ. Association between serum cytotoxicity and selected clinical variables in 240 horses admitted to a veterinary hospital. Am J Vet Res 1992; 53. 748-752.
58. BEUTLER B, CERAMI A. Cachectin: more than a tumor necrosis factor. N Ensl J Med 1987; 316: 379-385.
59. GELLER DA, NUSSLER AK, DI SILVIO M, LOWENSTEIN CJ, SHAPIRO RA, WANG SC, SIMMONS RL, BILLIAR TR. Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc Natl Acad Sci USA 1993; 90: 522-526.
60. PITTNER RA, SPITZER JA. Endotoxin and TNF alpha directly stimulate nitric oxide formation in cultured rat hepatocytes from chronically endotoxemic rats. Biochem Biophys Res Commun 1992; 185: 430-435.
61. PALMER RM, FERRIGE AG, MONCADA S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-526.
62. KILBOURN RG, GROSS SS, JUBRAN A, ADAMS J, GRIFFITH OW, LEVI R. NG-methyl-1-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide. Proc Natl Acad Sci USA 1990; 87: 3629-3632.
63. PENNICA D, NEDWIN GE, HAYFLICK JS, SEEBURG PH, DERYNCK R, PALLADINO MA, KOHR WJ, AGGARWAL BB, GOEDDEL DV. Human tumor necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature 1984; 312: 724-729.
64. SU X, MORRIS DD, MCGRAW RA. Equine tumor necrosis factor alpha: Cioning and expression in Escherichia coli generation of monoclonal antibodies, and development of a sensitive enzyme linked immunoabsorbent assay. Hybridoma 1992; 11: 715-727.
65. PENNICA D, HAYFLICK JS, BRINGMAN TS, PALLADINO MA, GOEDDEL DV. Cloning and expression in Escherichia coli of the cDNA for murine tumor necrosis factor. Proc Natl Acad Sci USA 1985; 82: 6060-6064.